Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol

BACKGROUND: Improved risk stratification, more effective therapy and better supportive care have resulted in survival rates after childhood cancer of around 80% in developed countries. Treatment however can be harsh, and three in every four childhood cancer survivors (CCS) develop at least one late...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Kooi, Anne-Lotte L. F., Clemens, Eva, Broer, Linda, Zolk, Oliver, Byrne, Julianne, Campbell, Helen, van den Berg, Marleen, Berger, Claire, Calaminus, Gabriele, Dirksen, Uta, Winther, Jeanette Falck, Fosså, Sophie D, Grabow, Desiree, Haupt, Riccardo, Kaiser, Melanie, Kepak, Tomas, Kremer, Leontien, Kruseova, Jarmila, Modan-Moses, Dalit, Ranft, Andreas, Spix, Claudia, Kaatsch, Peter, Laven, Joop S. E., van Dulmen-den Broeder, Eline, Uitterlinden, André G., van den Heuvel-Eibrink, Marry M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158859/
https://www.ncbi.nlm.nih.gov/pubmed/30257669
http://dx.doi.org/10.1186/s12885-018-4834-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158859/
https://www.ncbi.nlm.nih.gov/pubmed/30257669
http://dx.doi.org/10.1186/s12885-018-4834-3

Ejemplares similares